Hormone replacement therapy and cognition: Systematic review and meta-analysis

JAMA

Volumn 285, Issue 11, 2001, Pages 1489-1499

  Leblanc, E S ^a   Janowsky, J ^a   Chan, B K S ^a   Nelson, H D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ATTENTION; CASE CONTROL STUDY; CLINICAL TRIAL; COGNITION; CONCEPT FORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; FEMALE; HORMONE SUBSTITUTION; HUMAN; MEDICAL INFORMATION; MENOPAUSE; META ANALYSIS; MOTOR PERFORMANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; VERBAL MEMORY; WORKING MEMORY;

EID: 0035925762     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.11.1489     Document Type: Review

References (67)

1. Lifelong estrogen exposure and cognitive performance in elderly women
2. Association between bone mineral density and cognitive decline in older women
3. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
4. Estrogen-related variation in human spatial and articulatory-motor skills
5. Visual cerebral lateralization over phases of the menstrual cycle: A preliminary investigation
6. Reciprocal effects of hormonal fluctuations on human motor and perceptualspatial skills
7. Distribution and hormone regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female rats
8. Expression of estrogen receptor α and β transcripts in female monkey hippocampus and hypothalamus
9. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system
10. Neuroanatomy of memory
11. The role of the left hippocampal region in the acquisition and retention of story content
12. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women
13. Postmenopausal estrogen replacement therapy and risk of AD: A population-based study
14. A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics
15. Best practice synthesis: An alternative to meta-analytic and traditional reviews
16. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
17. Current methods of the Third US Preventive Services Task Force: A review of the process
18. Bias in meta-analysis detected by a simple, graphical test
19. The influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women
20. Estrogen replacement therapy and longitudinal decline in visual memory: A possible protective effect?
21. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging
22. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
23. Estrogen replacement therapy and risk of Alzheimer disease
24. Lack of postmenopausal estrogen replacement therapy and the risk of dementia
25. Estrogen replacement therapy in older women: Comparisons between Alzheimer's disease cases and nondemented control subjects
26. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based casecontrol study
27. A case-control study of Alzheimer's disease
28. A case-control study of Alzheimer's disease in Australia
29. Risk factors for clinically diagnosed Alzheimer's disease: A case-control study of an Italian population
30. Alzheimer's disease: A study of epidemiological aspects
31. Sex steroids modify working memory
32. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks
33. The effect of short-term estrogen replacement therapy on cognition: A randomized, double-blind, cross-over trial in postmenopausal women
34. Effects of estrogen on memory function in surgically menopausal women
35. Estrogen improves psychological function in asymptomatic postmenopausal women
36. Replacement therapy and piperazine oestrone sulphate ("Harmogen") and its effect on memory
37. A double-blind study into the influence of estriol on a number of psychological tests in post-menopausal women
38. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project
39. Estrogen use, APOE, and cognitive decline: Evidence of gene-environment interaction
40. Relationships among cortisol (CRT), dehydroepiandrosterone-sulfate (DHEAS), and memory in a longitudinal study of healthy elderly men and women
41. Estrogen replacement therapy and cognitive decline in older community women
42. Cognitive function in nondemented older women who took estrogen after menopause
43. Estrogen replacement therapy and cognitive function in older women
44. Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women
45. Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study
46. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance
47. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women
48. Estrogen replacement therapy and memory in older women
49. Estrogen use and verbal memory in healthy postmenopausal women
50. Informants' knowledge of reproductive history and estrogen replacement
51. Use of hormone replacement therapy by postmenopausal women in the United States
52. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities
53. Prior to use of estrogen replacement therapy: Are users healthier than nonusers?
54. The clinical epidemiology of Alzheimer's disease
55. Epidemiology of Alzheimer's disease
56. Postmenopausal estrogen and prevention bias
57. Memory, thinking, and aging: What we know about what we know
58. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study
59. Estrogen for Alzheimer's disease in women
60. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial
61. Estrogen, cognition, and a woman's risk of Alzheimer's disease
62. The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia
63. Megatrials of hormonal replacement therapy
64. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females